M Giraudon

Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration

Usha Chakravarthy, Clare Bailey, David M. Brown et al. · Ophthalmology Retina · 2017 · 83 citations · Full text

Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals

Heidemarie Kletzl, M Giraudon, Patricia Sanwald Ducray et al. · Anti-Cancer Drugs · 2015 · 72 citations

Medicinal Chemistry, Gastric Ph, Erlotinib Dose +12

A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail

Peter N. Morcos, Linda Chang, Rohit Kulkarni et al. · European Journal of Clinical Pharmacology · 2013 · 26 citations

Hepatology, Hepatitis C, Viral Hepatitis +11

2126. Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious <i>Acinetobacter</i> Infections

Andreas Guenther, Laurie Millar, Amanda Messer et al. · Open Forum Infectious Diseases · 2023 · 15 citations · Full text

Mg Zosurabalpin, Pharmacotherapy, Antimicrobial Chemotherapy +23

Pharmacokinetics and safety of oseltamivir in patients with end‐stage renal disease treated with automated peritoneal dialysis

Kashyap Patel, Craig R. Rayner, M Giraudon et al. · British Journal of Clinical Pharmacology · 2014 · 13 citations · Full text